Return
Therapeutic-drug-monitoring-based ATG Targeted Dosing Strategy in Unmanipulated Haploidentical Haematopoietic Stem Cell Transplantation: a randomized, multicenter, phase 3 clinical trial
L
N
H
J
J
Q
X
F
J
H
W
X
D
DOI:10.1016/j.canlet.2026.218766.png)
Abstract
En 中文
• Therapeutic-drug-monitoring-based ATG dosing for the common GVHD prophylaxis. • Improvement in GRFS, CMV reactivation and cGVHD. • Infections were reduced, without increasing GVHD. • Immune reconstitution was enhanced.
Journal
IF:
10.1
Papers:
1.7W
Citations:
4.3W
